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   Abstract 
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 Citrus unshiu peel is a Korean citrus fruit that has abundant 
bioactive compounds including flavonoids like naringin, hesperidin, and 
narirutin. In this study, we examined the anti­obesity and 
anti­hyperglycemia effects of citrus unshiu peel extract fermented by 
mycotoxin non­producing Aspergillus niger FMB S46494 using 
high­fat diet induced obese mice. The total flavonoid contents of 
citrus unshiu peel extract (CPE) and fermented citrus unshiu peel 
extract (FCPE) were 55.6 mg/g NE (naringin equivalents) and 173.5 
mg/g NE respectively. The contents of flavonoid were determined by 
HPLC. Narirutin and hesperidin were the major flavonoids in citrus 
peel extract. Naringenin level reached 14.1 mg/g after fermentation.   
 Four­week­old male C75BL/6J mice were divided into five groups 
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(n = 8) and fed the respective experimental diets for 13 weeks ; 
LFD (low­fat diet), HFD (high­fat diet), CPE (HFD + 1% (w/w) 
CPE), FCPE 0.3% (HFD + 0.3% (w/w) FCPE) and FCPE 1% (HFD + 
1% (w/w) FCPE). FCPE 0.3% group and FCPE 1% group had 
significantly lower body weight gains (14.1% and 13.2% less 
respectively, p＜0.05) and epididymal fat weight (28.8% and 23.5% 
less respectively, p＜0.05). The fasting blood glucose levels were 
significantly lower in the FCPE groups in comparison to the HFD 
group (p＜0.05). In intraperitoneal glucose tolerance test, AUC level 
was significantly lower in the FCPE 0.3% group compared to the HFD 
group (p＜0.05). In morphology of liver, lipid droplet accumulation 
was less pronounced in the FCPE  0.3% group and FCPE 1% group. 
Adipocyte size of epididymal fat was lower in the FCPE groups. 
Furthermore, the levels of total cholesterol and LDL cholesterol in 
plasma were significantly lower in the FCPE groups (p＜0.05). 
Expression of genes related to hepatic glucose homeostasis (Gk, 
G6pase, Pepck), hepatic glucose transporter (Glut2), hepatic 
lipogenesis and fatty acid oxidation (Srebp1c, Acc, Fas, Cpt1) as well 
as hepatic cholesterol homeostasis (Srebp2, Hmgr, Pcsk9, Acat2, 
Cyp7a1, Ldlr) were determined by real­time PCR. The mRNA levels 
of Gk, Glut2 and CPT1 were significantly higher in the FCPE groups 
compared with the HFD group (p＜0.05). In addition, FCPE groups 
had significantly lower Srebp1c, Srebp2, Fas, Acc, Hmgr and Pcsk9 
mRNA expression (p＜0.05). In conclusion, FCPE supplementation 
may function to improve hepatic lipid and cholesterol metabolism as 
well as hepatic glucose metabolism in high­fat fed mice. These 
results suggest that FCPE, which contains naringenin, is a fermented 
food material that has promising effect in amelioration of obesity and 
obesity­induced hyperglycemia. 
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1. Introduction 
Obesity is a serious problem with a high public­health impact that 
may cause type 2 diabetes and metabolic syndrome (MetS)[1]. The 
MetS is associated with a large mortality worldwide, which is a 
cluster of insulin­resistance, diabetes, dyslipidemia, visceral obesity 
and hypertension [2, 3]. Recently, there have been growing interests 
in bioactive substance from natural food materials which can 
ameliorate the obesity and metabolic syndrome without side effects 
[4]. 
 Citrus fruits have abundant flavonoid compounds, which are classified 
as the six groups; flavanones, flavanans, isoflavones, flavonols, 
anthocyanidins and flavanols according to their structural 
characteristics [5]. Flavonoids have been widely known to possess 
biological activities with strong anti­oxidant properties. Citrus 
flavonoids have anti­obesity, anti­inflammatory and anti­diabetic 
effects in vitro and in vivo [6, 7, 8]. Citrus unshiu (Citrus unshiu 
Marcorv., Family: Rutaceae Citrus unshiu Marcorv., Family: Rutaceae) 
is a Korean citrus fruit that accounts for 30% of total fruits produced 
in Korea [9]. Traditionally, citrus peels have been used in Asia 
countries as a folk medicine [10]. It was reported that citrus peels 
have higher concentrations of flavonoid than the flesh part [11]. It 
has been demonstrated that citrus unshiu peels have a positive effect 
on inflammation [12]. Mice fed citrus unshiu peel showed a significant 
decrease in body weight gain and epididymal white adipose tissue 
weight. In addition, significant decrease in blood glucose level in mice 
fed citrus unshiu peel was partially mediated through the inhibition of 
gene expression of hepatic gluconeogenic enzyme and the induction of 
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insulin/glucagon secretion. The amelioration of hepatic steatosis of 
citrus unshiu peel was correlated to the inhibition of gene expression 
related to the lipogenesis and fatty acid oxidation in the liver [9].
 Major flavonoids in citrus unshiu peels exist as flavanone glycosides 
(narirutin, naringin and hesperidin) [13, 14]. However, glycoside is 
absorbed slowly because glycoside is broken down to aglycoside form 
by microflora of the large intestine and then absorbed from the 
intestine [15]. Therefore, glycoside forms require hydrolysis to 
aglycone forms for the improvement of bioavailability [16]. 
Bioconversion of Jeju Hallabong tangor peels with cytolase may enrich 
aglycoside flavanones, naringenin and hesperetin, and it enhanced the 
anti­inflammatory effects of citrus peels in RAW 264.7 cells 
compared to flavanone glycosides [17]. Aglycone form of flavonoid in 
the fermented citrus peel extract inhibited oxidative damage in 
pancreatic beta cell [13]. Previous study suggested that naringenin, 
which is an aglycoside form of narirutin and naringin, suppress 
diet­induced weight gain and prevent dyslipidemia by inhibiting gene 
expression of Srebp1c and activating hepatic fatty acid oxidation. In 
addition, naringenin treatment improved insulin sensitivity and glucose 
tolerance [18]. Naringenin supplementation (0.003%, 0.006% and 
0.012% of diet) upregulated fatty acid oxidation target genes in the 
hepatic tissue, resulting in lowered plasma level of triglyceride and 
total cholesterol and triglyceride contents in liver and adipose tissue 
[19]. 
 
 Fungal fermentation is one of the oldest biotechnologies and an 
inexpensive technique that enhances nutrient content of foods or 
other desirable attributes [20]. Aspergillus niger is widely used in the 
fermentation process due to its ability to produce various 
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glycosidases. In addition, A. niger was used to produce enzyme that 
hydrolyses naringin to naringenin [21, 22]. Citrus peel extract 
biotransformed with A. niger had more physiological effect than 
non­fermented citrus peel extract through the fermentation[23]. 
Therefore, we assumed that fermentation would improve several 
physiological effects of citrus unshiu peel extract.
 Although previous studies revealed that the effect of citrus unshiu 
peel extract on hyperglycemia and dyslipidemia in db/db mice, 
research on the protection of obesity and obesity­induced 
hyperglycemia using citrus unshiu peel extract and fermented citrus 
unshiu peel extract remains insufficient. Thus, this study investigated 
whether citrus unshiu peel extracts after fermentation by mycotoxin 
non­producing Aspergillus niger FMB S46494 ameliorated the obesity 
and its related hyperglycemia in high­fat diet fed C57BL/6J mice. 
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2. Materials and method
2.1. Preparation of extracts 
 Dried citrus unshiu peels were purchased from Barun Yakcho 
(Yongin, Korea). Samples were prepared by adding 6 L of 70% 
ethanol to 600 g of dried citrus peel. Extraction was performed at  
70℃ for 4 h, and then the solution was cooled and filtered with 
Whatman paper (No. 41). The filtered solution was concentrated with 
a speed vacuum (Scanspeed 40, LaBoGene Aps, Denmark), 
freeze­dried to a powder at -80℃ with a freeze dryer (FD8508, 
Ilshin BioBase, Korea) and stored at  -20℃ until use. 
2.2. Fungal strains and cultures
 A. niger FMB S46494 strain was provided by the Food Microbiology 
Laboratory at the Food and Nutrition Department at Seoul National 
University. Aspergillus niger FMB S46494 do not produce mycotoxin 
[24]. A niger was grown on potato dextrose agar (PDA) (Becton, 
Dickinson and Company, MD, USA) at 30℃ under aerobic conditions 
for 7 days. The spores from the subcultured PDA plate were 
scrapped and suspended in the 0.9% NaCl solution with 0.005% 
Tween 80 to make spore suspension solution. 
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2.3. Fermentation of citrus unshiu peel extracts 
 The dried citrus unshiu powder (1 g) was mixed with 30 ml of 
distilled water and sterilized in an autoclave at 121℃ for 15 min. A. 
niger FMB S46494 spores were inoculated at 106 spores/ml into the 
citrus peel suspension and fermented in a shaking incubator at 30℃ 
under 150 rpm for 7 days. The fermented extract was freeze­dried 
at -80℃ with a freeze dryer (FD8508, Ilshin BioBase, Korea), then 
extracted with 70% ethanol overnight at room temperature. The 
extract was filtered with Whatman paper (No. 41).
2.4. Measurement of total flavonoid contents
 Total flavonoid contents were analyzed according to the method 
[25]. The sample (15 µl) was mixed with 150 µl of diethylene glycol 
and 15 µl of 1 N NaOH. The mixture was shaken thoroughly, and 
incubated for 1 h at room temperature. The absorbance of the 
solution showing orange­yellowish in color, was measured at 420 nm. 
The result was determined using a standard calibration curve obtained 
from various concentrations of naringin (25, 50, 100, 200 and 400 
mg/l). Total flavonoid content of the sample was expressed as 
naringin equivalents in mg/g NE of dried powder. 
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2.5. Analysis of flavonoid composition by HPLC
The freeze­dried powder of citrus peel extract (CPE) and 
fermented citrus peel extract (FCPE) were dissolved in dimethyl 
sulfoxide (DMSO)­methanol for experiment. The extracted solution 
was filtered through a 0.2 ㎛ syringe filter (PALL Life Sciences, 
USA) before high­performance liquid chromatography (HPLC) 
analysis.
 The system used for HPLC analysis was the 1090 Series­ⅡModel 
HPLC System (Hewlett Packard, USA). The flavonoid compounds 
were monitored at 280 nm using an Eclipse XDB­C18 column (150 
mm long, 3mm inside diameter, 5 ㎛ particle size; Agilent 
Technologies, USA). The column temperature was 35℃, and the flow 
rate was 0.5 mL/min. The UV detection wavelength was 280 nm. The 
mobile phase consisted of two solvents: 0.1% acetic acid (A) and 
100% acetonitrile (B). The solvent gradient in volume ratios was as 
follows: 0­15 min 10­20% B, 15­25 min 20­25% B, 25­30 min 
25­30% B, 30­35 min 30% B.
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2.6. Animals and diets
 Four­week­old male C57BL/6J mice were purchased from Central 
Laboratory Animal Inc. (Seoul, Korea). The mice were maintained at 
23±3℃ with relative humidity of 50±10% and a 12 h/12 h light/dark 
cycle. Mice were randomly divided into five groups (n = 8) after two 
weeks of acclimation period ; LFD (low fat diet containing 10.2% kcal 
fat, 69.8% kcal carbohydrate, 20.1% kcal protein, TD.06416, Harlan 
Teklad), HFD (high fat diet containing 60.3% kcal fat, 21.3% kcal 
carbohydrate and 18.4% kcal protein, TD.06414, Harlan Teklad), CPE 
(HFD + 1% (w/w) CPE powder), FCPE 0.3% (HFD + 0.3% (w/w) 
FCPE powder), and FCPE 1%(HFD + 1% (w/w) FCPE powder). The 
caloric density of the low fat diet and high fat diet was 3.7 kcal/g and 
5.1 kcal/g respectively. The mice were allowed free access to water 
and  diet.
Mice were fed ad libitum for 13 weeks. Food intake and body weight 
were measured every other day and once a week, respectively. At 
the end of experimental period, mice were fasted for 12 h and 
anaesthetized with Zoletil (Virbac Lab., Carros, France)/Rompun 
(Bayer, Leverkusen. Germany), and blood samples were collected by 
cardiac puncture through heparin­coated tube. The Zoletilel/Rompun 
solution was diluted with saline and injected into thigh muscle. The 
livers and adipose tissues were removed, weighted and frozen at     
–70℃ until analyzed. All studies and protocol of the animals were 
approved by Institutional Animal Care and Use Committee (IACUC) 
(Seoul National University, Korea).
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2.7. Intraperitoneal glucose tolerance test (IPGTT)
 At the 12th week of treatment, fasting blood glucose levels were 
measured via tail vein with Accu­check Active (Roche Diagnostics, 
Indianapolis, IN, USA) after an overnight fasting. Additional blood 
glucose levels were measured at 15, 30, 60, and 120 min after 
glucose solution (2 g/kg body weight) administration by 
intraperitoneal injection.
2.8. Analysis of plasma lipid levels
  
 The plasma levels of triglyceride (TG), total­cholesterol (TC) and 
high density lipoprotein cholesterol (HDL­C) were analyzed by 
enzymatic methods using commercial assay kits (Asan Pharmaceutical 
Co., Seoul, Korea). The levels of low density lipoprotein cholesterol 
(LDL­C) were calculated by applying the formula ; LDL­C = TC- 
(TG/5) – HDL­C.
2.9. Histological analysis of liver and epididymal fat
 Morphological analysis of liver and epididymal fat tissue were 
conducted to determine hepatic lipid droplet accumulation and 
adipocyte size of the epididymal fat. Liver and epididymal fat were 
fixed overnight in 10% neutral formalin (Wako Pure Chemical 
Industries, Japan) and embedded in paraffin. The 4­㎛ sections were 
prepared, stained with haematoxylin­eosin and viewed under an 
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optical microscope (Olympus, Japan) with a magnifying power of 
×200. Cell length (㎛) of  12 adipocytes per group was measured 
with the open­source image analysis program ImageJ.
2.10. RNA extraction and quantitative real­time 
reverse transcriptase polymerase chain reaction 
(RT­PCR).
 Total RNA from the liver was isolated using TaKaRa MiniBEST 
Universal RNA Extraction kit (Takara Bio Inc, Japan) according to the 
manufacturer’s instructions. The purity and concentration of RNA 
were evaluated using a Nano­Spectrophtometer (NANO­200, 
BIOAND, Korea). Total RNA (500 ng) was reverse­transcribed to 
cDNA using the PrimeScript RT Master Mix (Takara Bio Inc, Japan). 
mRNA expression was analyzed by real­time quantitative PCR with a 
SYBR premix Ex Taq (Takara Bio Inc, Japan) using StepOne 
Real­time PCR system (Applied Biosystems, CA, USA). The mRNA 
levels were normalized with GAPDH and expressed as values of 
relative expression compared to that of the HFD group. The initial 
denaturation was conducted at 95℃ for 30 s, then followed by 40 
cycles of 5 s at 95℃ and 34 s at 60℃.  The primer sequences are 
shown in Table 1.
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gene  sequence ( 5’→ 3’)
Gapdh
(forward) AGG TCG GTG TGA ACG GAT TTG
(reverse) TGT AGA CCA TGT AGT TGA GGT CA
Glut2
(forward) GGC TAA TTT CAG GAC TGG TT
(reverse) TTT CTT TGC CCT GAC TTC CT
Gk
(forward) CAG GAC AGT GGA GCG TGA AGA C
(reverse) TTA CAG GGA AGG AGA AGG TGA AGC
G6pd
(forward) AAC GCC TTC TAT GTC CTC TTT C
(reverse) GTG GTT GCT GTA GTA GTC GGT GTC C
Pepck
(forward) TGC CTC TCT CCA CAC CAT TGC
(reverse) TGC CTT CCA CGA ACT TCC TCA C
Hmgr
(forward) TTC ACG CTC ATA GTC GCT GGA TAG
(reverse) TGG TTC AAT TCT CTT GGA CAC ATC TTC
Srebp1c
(forward) CGG AAG CTG TCG GGG TAG 
(reverse) GTT GTT GAT GAG CTG GAG CA
Srebp2
(forward) GCT GGT TTG ACT GGA TGG TT
(reverse) ACC TTT GGC GAG GTC TAG GT
Ldlr
(forward) ACC CCT CAA GAC AGA TGG TC
(reverse) CAG CCC AGC TTT GCT CTT AT
Cyp7a1
(forward) GTG GTA GTG AGC TGT TGC ATA TGG
(reverse) CAC AGC CCA GGT ATG GAA TCA
Pcsk9
(forward) TTG GAT TGA GGC CAT AGG AG
(reverse) GAC GGC ATA GAC ACC CTC AC
Acat2
(forward) GCA GGG AAG TTT GCC AGT GAG A
(reverse) GAA CAC GGT CTT GAG CTT TGG C
Fas
(forward)CTG AGA TCC CAG CAC TTC TTG A
(reverse)GCC TCC GAA GCC AAA TGA G
Acc
(forward)GAA TCT CCT GGT GAC AAT GCT TAT T
(reverse)GGT CTT GCT GAG TTG GGT TAG CT
Cpt1
(forward)ATC TGG ATG GCT ATG GTC AAG GTC 
(reverse)GTG CTG TCA TGC GTT GGA AGT C




 The results were expressed as mean±standard error of means 
(S.E.M.). Statistical differences were evaluated by one­way analysis 
of variance (ANOVA) followed by the Duncan’s multiple range tests 
using the SPSS statistical package (Chicago, IL, USA). Significant 
results were considered at p < 0.05.
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 3. Results 
3.1. Total flavonoid contents  
 The total flavonoid contents in the dried powder of the CPE and 
FCPE were 55.6 mg NE/g  and 173.5 mg NE/g of dry material 
respectively. The final percentage yield from the lyophilized powder 
of the CPE and FCPE were 32.4% and 12.7% respectively.
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3.2. Flavonoid composition
 The flavonoid components of CPE and FCPE were analyzed through 
the HPLC analysis. Table 2 shows the flavonoid composition of CPE 
and FCPE. The major flavonoids in CPE were narirutin (17.5 mg/g) 
and hesperidin (8.8 mg/g), and those in FCPE were narirutin        
(35 mg/g), hesperidin (21.9 mg/g). In addition, naringenin at the level 
of 14.13 mg/g, which is aglycone­form of narirutin, was found in the 
fermented sample. However, hesperetin, which is aglycone­form of 
hesperidin, was not found.
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Table 2.  Composition of the flavonoid from CPE and FCPE 
*ND : Not detected 
   Sample
          Flavonoid contents (mg/g dry weight)
     Narirutin     Hesperidin   Naringenin 
    CPE       17.5        8.8       ND*
    FCPE       35.0       21.9      14.1
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3.3. Food intake, body weight, epididymal fat weight 
and liver weight
 
 Table 3 and Fig. 1 show the body weight changes and the amounts 
of food intake. Final weight and body weight gain in the both FCPE 
0.3% and FCPE 1% group were significantly lower compared to the 
HFD group and CPE group. But there was no significant difference in 
the body weight between the CPE group and HFD group. The average 
daily food intake in the HFD group was the lowest among the 
experimental groups. Thus, mice fed CPE and FCPE supplementation 
showed significantly lower food efficiency ratio (FER) than the HFD 
group. The mice fed high fat diet with CPE and FCPE supplementation 
had significantly lower amount of the epididymal fat pad compared to 
the mice fed only high fat diet (Fig. 2A). However, the liver weights 
and liver­to­body weight percentage of the CPE and FCPE 
supplementation groups were not significantly altered (Fig. 2B and 
Fig. 2C). 
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LFD HFD CPE FCPE 0.3% FCPE 1%
Initial BW* (g) 21.9 ± 1.5 21.4 ± 0.9 21.5 ± 1.4 21.5 ± 0.9 21.4 ± 1.2
Final BW(g) 31.6 ± 3.1c 47.0 ± 2.1a 46.9 ± 1.4a 43.5 ± 3.9b 43.6 ± 2.3b
BW gain (g) 9.8 ± 2.1c 25.6 ± 2.1a 25.4 ± 2.1a 22.0 ± 3.1b 22.3 ± 2.1b
Food intake (g/day) 2.6 ± 0.3a 2.3 ± 0.2c 2.6 ± 0.2b 2.5 ± 0.2b 2.5 ± 0.2b
FER** 4.1 ± 0.9d 12.0 ± 1.0a 10.9 ± 0.9b 9.6 ± 1.3c 9.9 ± 0.9bc
Table 3. Food intake, body weight and food efficiency ratio.
*BW ; Body weight
**FER, food efficiency ratio = total body weight gain (g)/ total food intake (g) × 100.
The data are mean±S.E.M.(n=8 for each group).
abcdMeans in the same row not sharing a common letter are significantly different groups at p < 0.05. 
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    Fig. 1. Body weight curves of mice.
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A                                    B
             C
Fig. 2. Epididymal fat weight and liver weight.
A, epididymal fat weight ; B, liver weight ; C, liver­to­body 
weight percentage (%).
*Liver­to­body weight percentage(%) = liver weight (g)/ body weight 
(g) × 100. The data are mean±S.E.M.(n=8 for each group).
abcMeans in the same row not sharing a common letter are significantly 
different groups at p < 0.05. 
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3.4. Fasting blood glucose level and glucose 
tolerance test
 
 Fig 3 shows the fasting blood glucose levels after 12 weeks of 
experimental feeding. The fasting blood glucose levels in the 
FCPE 0.3% and FCPE 1% groups were significantly lower than 
these in the HFD group and CPE group.  
 IPGTT was further performed at 12th week (Fig.4 and Table 4). 
Compared to the HFD group, FCPE 0.3% group exhibited 
significantly lower blood glucose levels at 60 and 120 min after 
the injection of glucose and FCPE 1% group showed significantly 
lower blood glucose level at 120 min. However, the blood 
glucose levels following the administration of glucose solution did 
not differ between the CPE and HFD group. Based on the result 
of IPGTT, the AUCs were calculated by the excel program. The 
FCPE 0.3% group showed significantly lower AUC level than the 
HFD group (Fig. 4B). 
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 Fig. 3. Fasting blood glucose levels at 12th week.
The data are mean±S.E.M.(n=8 for each group). abcMeans in the same 






Fig. 4. The result of IPGTT at 12th week. 
A, Serum glucose levels at 0, 15, 30, 60 and 120 min after the 
glucose solution injection (mg/dl) ; B, Caculated AUCs (area 
under the curve) 
The data are mean±S.E.M.(n=8 for each group). abcMeans in the same 





LFD HFD CPE FCPE 0.3% FCPE 1%
0 min  94.9 ± 13.7c 134.0 ± 13.4a 136.5 ± 17.7
a
114.9 ± 13.3b 120.5 ± 11.1b
15 min 303.6 ± 37.3b 350.5 ± 33.7ab 345.4 ± 55.6ab 335.5 ± 56.6ab 382.5 ± 33.2a
30 min 323.8 ± 44.9b 492.6 ± 57.1
a 464.0 ± 52.0a 450.3 ± 41.0a 451.8 ± 57.8a
60 min 243.4 ± 40.0c 400.3 ± 48.1a 381.8 ± 65.4ab 358.3 ± 43.9b 383.8 ± 33.1ab
120 min 163.1 ± 22.7b 260.9 ± 33.0
a 244.3 ± 49.9a 198.9 ± 28.9b 198.1 ± 26.3b
Table 4. The result of IPGTT at 12th week.
The data are mean±S.E.M.(n=8 for each group).
abcMeans in the same row not sharing a common letter are significantly different groups at p < 0.05.
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3.5. Histological analysis of liver 
  In contrast to the liver weights, the analysis of hepatic 
morphology demonstrated that the HFD and CPE group showed 
the highest lipid accumulation in the liver, while minimal hepatic 
lipid accumulation was found in the FCPE 0.3% group and FCPE 
1% group (Fjg. 5).  
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              LFD                              HFD
    
   
      
          
             CPE                               FCPE 0.3%
                   
           
                           FCPE 1%
Fig. 5. The morphology of hepatic tissue. 
Hepatic lipid droplet accumulation in liver sections stained with H&E. 
Magnification (×200).
- 25 -
3.6. Histological analysis of epididymal fat 
 The adipocyte sizes were significantly smaller in the CPE and 
FCPE supplementation groups than in the HFD group (Fig. 6 and 
Fig. 7). Fig. 6 shows lots of crown­like structures (CLSs) in 
the HFD group and CPE group. Apparently numerous 
macrophages were infiltrated into adipocytes to form crown­like 
structures. On the other hand, macrophage infiltration was 
inhibited in the FCPE 0.3% and 1% groups.
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             LFD                               HFD
      
      
      
      
      
      
             CPE                            FCPE 0.3%
                  
                        
                            
                        
                             FCPE 1% 
Fig. 6. The morphology of epididymal adipose tissue. 




Fig. 7. Adipocyte size in the epididymal adipose tissue. 
The data are mean±S.E.M. abcdMeans in the same row not sharing a 
common letter are significantly different groups at p < 0.05.
- 28 -
 3.7. Plasma lipid levels 
 The plasma TG levels and HDL­C levels were not significantly 
different among the experimental groups (Fig. 8A and 8C). 
However, the levels of TC were lower in the 0.3% FCPE and 
1% FCPE group. The HFD group and CPE group showed the 
significantly high levels of TC (Fig. 8B).
Furthermore, significant suppressions were observed in the LDL 
­C levels of the FCPE 0.3% and FCPE 1% groups compared to 
the HFD group. In contrast, the CPE group showed significantly 
higher level of LDL­C compared with the HFD group (Fig. 8D).
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A                                   B
C                                   D
Fig. 8. Plasma lipid profile. 
A, Triglyceride concentrations in plasma; B, Total cholesterol 
concentrations in plasma; C, HDL­C concentrations in plasma; D, 
LDL ­C conentraions in plasma. 
The data are mean±S.E.M.(n=8 for each group). abcMeans in the same 
row not sharing a common letter are significantly different groups at p 
< 0.05
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3.8. Expression of genes involved in hepatic 
glucose homeostasis and glucose transporter 
 We performed real­time PCR analysis to investigate the 
mechanism through which FCPE attenuates blood glucose levels 
(Fig. 9). FCPE supplementation groups showed significantly 
higher mRNA levels of Gk (glucokinase) than the control group. 
Moreover, FCPE 1% group had significantly higher expression of 
Glut2 (glucose transporter protein type 2) than the control 
group. Although CPE group had no effect on mRNA levels of Gk 
and Glut2, G6pase (glucose­6­phosphotase) mRNA level, 
gluconeogenic enzyme, was significantly lower than the control 
and FCPE 1% group. There was no difference in the mRNA 
levels of Pepck among the groups. 
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                 Gk                            Glut2
     
               G6pase                           Pepck
 
Fig. 9. The mRNA (Gk, Glut2, G6pase, Pepck) levels of genes 
related to hepatic glucose homeostasis and glucose transporter. 
The data are mean±S.E.M.(n=8 for each group). abcMeans in the same 
row not sharing a common letter are significantly different groups at p 
< 0.05.
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3.9. Expression of genes involved in hepatic 
lipogenesis and fatty acid oxidation
 To examine whether FCPE influenced hepatic lipogenesis and 
fatty acid oxidation, the mRNA levels of Srebp1c (sterol 
regulatory element binding protein 1c), Acc (acetyl­CoA 
carboxylase), Fas (fatty acid synthase) and Cpt1 (carnitin 
palmitoyl transferase 1) were measured (Fig. 10). FCPE 
supplementation groups showed significantly lower levels of 
Srebp1c than HFD group. The mRNA levels of Fas were 
significantly lower in the FCPE 0.3% and slightly reduced in the 
CPE and FCPE 1% group, whereas Acc mRNA levels were 
significantly lower in the FCPE 1% group and slightly lower in 
CPE and FCPE 0.3% group. Moreover, Cpt1 mRNA level was 
significantly higher in the FCPE 1% group than the HFD group. 
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               Srebp1c                           Acc
                                        
                 Fas                              Cpt1
Fig. 10. The mRNA (Srebp1c, Acc, Fas, Cpt1) levels of genes 
related to hepatic lipogenesis and fatty acid oxidation.
The data are mean±S.E.M.(n=8 for each group). abcMeans in the same 
row not sharing a common letter are significantly different groups at p 
< 0.05.
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 3.10. Expression of genes involved in hepatic 
cholesterol homeostasis
 To determine whether the effect of FCPE on low levels of TC 
and LDL­C in the plasma was associated with changes in genes 
related to cholesterol homeostasis in the liver, we measured the 
mRNA levels of Srebp2 (sterol regulatory element binding 
protein 2), Hmgr (HMG­CoA reductase), Pcsk9 (proprotein 
convertase subtilisin/kexin type 9), Ldlr (LDL receptor), Cyp7a1 
(cholesterol 7 alpha­hydroxylase) and Acat2 (acyl­CoA  
cholesterol acyltransferase 2) (Fig. 11 and Fig. 12). The mRNA 
levels of Srebp2 were significantly lower in the FCPE groups. 
The mRNA levels of Hmgr were also significantly lower in the 
FCPE 0.3% and FCPE 1% groups. In addition, the expression 
levels of Pcsk9, which could lead to the degradation of LDL 
receptor [26], were also significantly lower in the both FCPE 
groups. However, no significant differences were observed in 
mRNA levels of Ldlr, Cyp7a1 and Acat2 among the groups. 
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               Srebp2                           Hmgr
                
                Pcsk9                             Ldlr 
 
 Fig. 11. The mRNA (Srebp2, Hmgr, Pcsk9, Ldlr) levels of 
genes related to hepatic cholesterol homeostasis.
The data are mean±S.E.M.(n=8 for each group). abcdMeans in the same 
row not sharing a common letter are significantly different groups at p 
< 0.05.
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               Cyp7a1                            Acat2            
                               
Fig. 12. The mRNA (Cyp7a1, Acat2) levels of genes related to 
hepatic cholesterol homeostasis.
The data are mean±S.E.M.(n=8 for each group). abcMeans in the same 




This study investigated the anti­obesity and 
anti­hyperglycemia effect of fermented citrus unshiu peel 
extract in the high­fat diet fed mice. The present study showed 
that the FCPE supplementation groups had significantly lower 
body weight gains and epididymal fat weight compared to the 
HFD group. In addition, lipid droplet accumulation was less 
pronounced in the FCPE groups. Adipocyte size of epididymal fat 
was significantly lower in the FCPE groups. The levels of TC 
and LDL­C in plasma were significantly lower in the FCPE 
groups. Furthermore, the fasting blood glucose levels were 
significantly lower in the FCPE groups in comparison to the HFD 
group.
The major flavonoids in the CPE were narirutin and hesperidin 
in agreement with the other studies reporting that the major 
composition of the flavonoids in citrus unshiu peel extract were 
narirutin and hesperidin [27]. The narirutin content was higher 
than that of hesperidin content in the CPE, whereas other 
studies showed that hesperidin content was the highest among 
the flavonoids in the citrus unshiu peel extract [14, 27]. 
However, the glycoside forms, narirutin and hesperidin, require 
hydrolysis to convert them to their active aglycone forms, 
naringenin and hesperitin, for a more effective bioactivity [16]. 
Thus, citrus unshiu peel extract was fermented by mycotoxin 
non­producing Aspergillus niger FMB S46494 to convert 
glycoside form to the aglycone form. As a result, 14.1 mg/g of 
naringenin was found in the FCPE. A. niger FMB S46494 has 
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been shown to have a strong deglycosylating activity that 
efficiently transforms protopanaxadiol (PPD) type ginsenosides in 
the Korean ginseng berry to compound K, which is the 
deglycosylated forms, through fermentation [28]. 
 In the current study, high­fat diet successfully induced 
increase of body weight, epididymal fat weight and adipocyte 
size as well as elevated the plasma TC and LDL­C and 
deposition of hepatic lipid droplets in C57BL/6J mice. With FCPE 
supplementation, body weight and epididymal fat weight was 
lowered. Epididymal fat weight also lowered in the CPE group. 
The food intakes were rather increased in the CPE and FCPE 
groups. Thus, the FERs of CPE and FCPE were lower than that 
of the HFD. Therefore, mice fed CPE or FCPE supplementation 
showed lower efficiency of converting the feed nutrients into 
their own energy than mice fed only high­fat diet. These 
results are supported by a previous study which indicated that 
dietary citrus ichangensis peel extract in  high­fat induced mice 
also exhibited weight loss due to the flavanones such as naringin 
and hesperidin [29]. 
 Moreover, accumulation of lipid droplets in the liver was less 
pronounced in the FCPE supplementation groups. These results 
were accompanied by the down­regulation of Srebp1c, Fas and 
Acc. Srebp1c, which is a transcription factor, has a fundamental 
role in regulating de novo fatty acids synthesis by inducing the 
expression of the genes including Fas and Acc in the liver [30]. 
Fas and Acc are enzymes for de novo fatty acid synthesis. 
Moreover, the upregulated expressions of  Cpt1, which is a 
critical enzyme for fatty acid oxidation,  could lead to prevention 
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of lipid accumulation in the liver. Thus improvement in hepatic 
lipogenesis and fatty acid oxidation by FCPE supplementation 
contributes to attenuation of hepatic lipid accumulation. These 
findings correspond well with a previous report that naringenin 
supplementation prevented hepatic lipid accumulation by 
suppressing the expression of Srebp1c mRNA and stimulating the 
expression Cpt1 mRNA in the liver [18]. However, hepatic lipid 
accumulation was identified through the morphological analysis 
not through the measurement of TG and TC levels in the liver. 
Therefore, further measurement of the hepatic TG and TC 
contents to verify the effect of FCPE on hepatic steatosis will be 
necessary in the future study. 
 In addition, the levels of plasma TC and LDL­C were 
suppressed in the FCPE groups. This result was caused by 
suppression of the Srebp2, Hmgr and Pcsk9 mRNAs. Srebp2, 
which favors de novo cholesterol synthesis, induces the 
expression of HMG­CoA reductase, Pcsk9 and other enzymes of 
cholesterol biosynthesis pathway [31]. Hmgr is the rate­liming 
enzyme in the cholesterol biosynthesis pathway. Therefore, 
regulation of hepatic Hmgr is necessary to maintain cholesterol 
homeostasis in the circulation and liver [32]. Moreover, Pcsk9, 
which could lead to the degradation of LDL receptor [23], is 
known to prevent LDL uptake. Therefore, poor expression of 
Pcsk9 is correlated with reduced circulating LDL­C levels and 
cardiovascular risk [33]. Interestingly, these findings do not 
correspond with the results that citrus unshiu peel extract, which 
contains narirutin and hesperidin, and citrus depressa Hayata,  
which contain nobiletin and tangeretin, do not affect the plasma 
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total cholesterol [9, 34]. In contrast, naringenin, the aglycoside 
form of naringin and narirutin, supplementation reduced plasma 
and hepatic cholesterol concentrations by suppressing Hmgr in 
high­cholesterol diet fed rats [35, 36]. These findings suggest 
that naringenin in the FCPE may partially contribute to a 
significant reduction of plasma cholesterol levels.
 Furthermore, high­fat diet led to the elevation of fasting blood 
glucose levels and impaired glucose tolerance in this study. The 
high­fat diet could be the major cause of impaired glucose 
tolerance and condition of early type 2 diabetes in C57BL/6J 
mice [37]. In contrast to the HFD group, the FCPE 
supplementation groups showed a lower fasting blood glucose 
level and an attenuated impaired glucose tolerance than the HFD 
group. These positive effects seem to be associated with the 
enhanced Glut2 and Gk mRNA expression. Glut2, primarily found 
in cell membranes of liver, is a major glucose transporter. 
Increased expression of Glut2 in the liver could decrease blood 
glucose and insulin levels [38]. Gk  is an enzyme that 
phosphorylates glucose to glucose­6­phosphate. Increased 
intracellular glucose­6­phosphate by Gk  stimulates glycolysis 
and glycogen synthesis [39]. In addition, several studies have 
suggested that Glut2 and Gk  have central roles in the regulation 
of glucose metabolism [40, 41]. Previous studies have also 
shown that a normal diet with 2% citrus unshiu peel extract 
ameliorates hyperglycemia in db/db mice [9] and naringenin 
supplementation improved glucose tolerance in high­fat fed mice 
[18].
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 Surprisingly, the CPE did not exhibit beneficial effects on 
plasma lipids and blood glucose levels. This result is inconsistent 
with previous studies in which citrus unshiu peel extract 
ameliorated serum TG, hyperglycemia and hepatic lipid 
accumulation [9. 42]. The content of flavonoids, duration of 
study, differences in species and experimental food and 
significantly higher food intake than control group could have 
different effects on these results. 
Although other studies of citrus peel extract have demonstrated 
that flavonoids mainly have an effect on physiological effects, 
other components in CPE and FCPE might have partially 
contributed to the presently observed anti­obesity and 
anti­hyperglycemia effect.
In conclusion, naringin in citrus unshiu peel extract was 
converted into naringenin through fermentation with A. niger. 
FCPE supplementation resulted in lower the body weight gain, 
food efficiency ratio and epididymal fat weight. In addition, 
hepatic lipid accumulation and plasma TC and LDL­C levels 
were lowered by inhibiting the mRNA expression for fatty acid 
synthesis and cholesterol synthesis  and by activating the mRNA 
expression for fatty acid oxidation. Furthermore, FCPE lowered 
fasting blood glucose levels by up­regulating the GK and 
GLUT­2 mRNA expression. This result suggests that FCPE, 
which contains aglycoside flavanone, is a more potent material 
that could ameliorate obesity and obesity­induced hyperglycemia 
than that of CPE.
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                             국문초록 
 진피는 한국에서 생산되는 감귤의 껍질로써 플라보노이드를 포함한 다
양한 생리활성 물질을 함유하고 있다고 알려져 있다. 그 중 진피에는 헤
스페리딘, 나리루틴과 같은 플라보노이드를 풍부하게 함유하고 있으며, 
이 성분들은 비만, 간지방증, 당뇨 질환의 예방 및 개선효과 등 다양한 
생리적인 효과를 보인다고 보고되고 있다. 본 연구에서는 진피를 곰팡이 
독소를 생산하지 않는 Aspergillus niger FMB S46494로 발효하여 배
당체 형태의 나리루틴을 비배당체 형태의 나린제닌으로 전환하였다. 그 
후, 고지방 식이에 진피 추출물과 발효한 진피 추출물을 첨가하였을 때, 
비만과 고혈당에 미치는 영향을 확인하고자 하였다. HPLC 분석을 통해 
나리루틴과 헤스페리딘이 진피 추출물 속의 주요 플라보노이드 성분인 
것을 확인 하였으며, 발효 진피 추출물 속에는 나리루틴이 발효를 통해 
나린제닌으로 일정량 전환되어 14.1 mg/g이 검출되었다. 동물 실험을 
위해 4주령의 C57BL/6J 마우스를 각 여덟 마리씩 다섯 군으로 나눈 후 
다섯 가지 실험 식이를 각각 13주간 제공하였다. 실험 식이는 총 식이 
칼로리의 10%를 지방으로 공급하는 저지방 식이 (LFD), 총 식이 칼로
리의 60%를 지방으로 공급하는 고지방 식이 (HFD), 그리고 고지방 식
이에 진피 추출물을 1% 첨가한 식이 (CPE)와 발효 진피 추출물을 각
각 0.3%와 1%을 첨가한 식이 (FCPE 0.3% 또는 FCPE 1%)로 구성되
었다. FCPE 0.3%군과 FCPE 1%군에서는 HFD군에 비해 체중 증가량 
(p＜0.05)과 부고환 지방무게 (p＜0.05)가 유의적으로 낮았다. 또한 공
복혈당 수치도 유의적으로 낮게 나왔으며, 포도당 내성 검사를 통해 
FCPE 0.3%군, FCPE 1%군은 포도당 투여 각각 60분, 120분 후부터 
유의성 있는 혈당 감소를 보였다 (p＜0.05). 혈청 지질 검사를 통해 
FCPE군 모두 총 콜레스테롤 수치와 LDL 콜레스테롤 수치가 HFD군에 
비해 유의적으로 낮은 것(p＜0.05)을 확인하였다. 간에서 해당과정과 
당신생 과정에 참여하는 효소 (Gk, G6pase, Pepck), 간 내 포도당 운
반체 (Glut2), 간에서의 지방산 합성과 산화 (Srebp1c, Acc, Fas, 
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CPT1), 간에서의 콜레스테롤 항상성 (Srebp2, Hmgr, Pcsk9, 
Cyp7a1, Acat2, Ldlr) 관련 유전자의 mRNA 발현량을 Real­time 
PCR 로 측정하였다. 간에서 Gk, Glut2 와 CPT1이 FCPE군들에서 높
은 발현량을 보였다. 또한 Srebp1C, Srebp2, Acc, Fas, Hmgr 및 
Pcsk9은  FCPE군들에서 모두 낮은 발현량을 보였다. 이를 통해 발효 
진피 추출물이 혈액으로부터 간으로의 당의 흡수와 간에서의 지방산 산
화를 촉진시키며, 반대로 간에서 지방산 및 콜레스테롤 생성을 억제할 
수 있다는 것을 알 수 있다. 결론적으로 본 연구에서는 발효를 통해 배
당체 형태의 플라보노이드인 나리루틴이 비배당체 형태인 나린제닌으로 
전환되었으며, 나린제닌이 함유된 발효 진피 추출물이 비만과 고혈당을 
개선할 수 있음을 시사한다.
주요어: 진피, 발효, Aspergillus niger, 플라보노이드, 항비만, 고혈당개
선
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